PerspectivePublished 12 October 2026Precision targeting of type 2 inflammation in COPD: identifying candidates for dupilumab therapyKezhuo Zhong · Kaiying Lv · Qun LiangFrontiers in Pharmacologydoi 10.3389/fphar.2026.1971309
Systematic ReviewPublished 12 October 2026Procedural interventions for chronic migraine: an umbrella review intervention-specific evidence mapLijie Xia · Dianhui Yang · Yan Lu · Yunfei Gong · Chengtao ZhangFrontiers in Neurologydoi 10.3389/fneur.2026.1915292
Original ResearchPublished 9 October 2026Clinical challenges in vaccine and monoclonal antibody development against ESCAPE pathogens: insights from EMA scientific advice proceduresIgor Stojkov · Linda Marchioro · Isabelle Bekeredjian-Ding · Benjamin HofnerFrontiers in Medicinedoi 10.3389/fmed.2026.1931144
Systematic ReviewPublished 7 October 2026Biologics and JAK inhibitors for atopic manifestations in inborn errors of immunity: a systematic reviewMahnaz Jamee · Roba Maher Al-Gaweesh · Amirhossein Hajialigol · Sally Gouda Mohammed · Peyman Tirandazi · Abdullah A. Alangari · Rasha El-OwaidyFrontiers in Allergydoi 10.3389/falgy.2026.1867183
Original ResearchPublished 2 October 2026Safety of lecanemab in real-world patients with Alzheimer’s disease: a prospective, observational case series supported by FAERS signal analysisHaixia Ji · Yang Yang · Xingqi Wu · Erhao BaoFrontiers in Neuroinformaticsdoi 10.3389/fninf.2026.1977226
PerspectivePublished 30 September 2026Glycan-intrinsic monoclonal antibody biomanufacturingAron GyorgypalFrontiers in Chemical Engineeringdoi 10.3389/fceng.2026.1955792
Original ResearchPublished 3 September 2026Clinical phenotypes, endotypes, and biomarker profiles of immediate rituximab hypersensitivity reactions: a prospective pharmacovigilance studyNarapong Yotinnoratham · Wannada Laisuan · Kumutnart Chanprapaph · Silada Kanokrungsee · Chavachol Setthaudom · Supornchai Onpun · Pungjai Mongkolpathumrat · Supranee Buranapraditkun · Apinya Chungcharoenpanich · Nichapha Dechapaphapitak · Supa Oncham · Nattakirana Tongdee · Sananya Khamkaew · Ratchaya Lertnawapan · Jettanong KlaewsongkramFrontiers in Allergydoi 10.3389/falgy.2026.1903523
Case ReportPublished 31 August 2026Persistent presumed allergic fungal rhinosinusitis during tezepelumab therapy with improvement after revision surgery: a case reportBashayer Saad Hamoud Alsultan · Aasem Gharamah Alshehri · Leen Abdulmohsin Sarhan · Ghadah Saad H. Alsultan · Yahya ShabiFrontiers in Allergydoi 10.3389/falgy.2026.1944701
Case ReportPublished 3 August 2026Eosinophilic cystitis refractory to multiple treatments with good response to benralizumab: case reportMarina Ruiz de Galarreta Beristain · María Teresa Audicana Berasategui · Nagore Bernedo Belar · Cristina Mena Ruiz · Virginia Moreno Nieto · Olga Uriel VillateFrontiers in Allergydoi 10.3389/falgy.2026.1890965
Original ResearchPublished 29 May 2026Identification of Fasciola hepatica gut-associated glycoproteins as potential vaccine candidates by lectin-affinity chromatography, flukicidal monoclonal antibodies, and affinity-enrichment mass spectrometrySonja G. Rechsteiner · Sina Hasler · Peter Gehrig · Peter Deplazes · Ramon M. EichenbergerFrontiers in Parasitologydoi 10.3389/fpara.2026.1746419
ReviewPublished 30 April 2026From biosimilars to breakthroughs: regulatory convergence toward evidence-efficient development of monoclonal antibodiesSarfaraz K. NiaziFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1778468
ReviewPublished 15 April 2026Analytical similarity as the primary determinant of monoclonal antibody development: toward evidence-efficient regulatory frameworksSarfaraz K. NiaziFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1801236
Case ReportPublished 13 April 2026Case Report: Pernicious anemia-associated pancytopenia responds to immunotherapyAlexander Krule · Carlos Murga-Zamalloa · Irum Khan · Ryan Sun · John G. QuigleyFrontiers in Hematologydoi 10.3389/frhem.2026.1733719
Case ReportPublished 14 January 2026Case Report: Biologic-free clinical remission following anifrolumab discontinuation in systemic lupus erythematosus—two-case reportsTakako Hashimoto · Hidekata YasuokaFrontiers in Lupusdoi 10.3389/flupu.2025.1737535
Original ResearchPublished 7 November 2025Trop2 expression, p16 expression status, and histologic subtype in carcinoma of the uterine cervixGrit Gesine Ruth Hiller · Benjamin Wolf · Mirjam Forberger · Annekathrin Freude · Christine Elisabeth Brambs · Svenja Droste · Lars-Christian Horn · Anne Kathrin HöhnPathology and Oncology Researchdoi 10.3389/pore.2025.1612252
Science archivePublished 9 July 2025Real-world safety and effectiveness of dupilumab for the treatment of atopic dermatitis: two-year post-marketing surveillance in JapanHidehisa Saeki · Makiko Usami · Katsuhisa Suzuki · Michika Mochizuki · Kazuhiko ArimaJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2025.14794